Atlas Trials

A Study to Assess the Potential for Pre-systemic Inhibition of CYP3A by Idebenone Using Midazolam as a Substrate

Clinical trial NCT02887443 · COMPLETED

Trial details

NCT number
NCT02887443
Sponsor
Santhera Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug-Drug Interaction
Start date
2016-09-01
Primary completion
2016-11-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.